EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective

Sandhya Chahal, Payal Rani, Kiran, Jayant Sindhu iD, Gaurav Joshi iD, Aravindhan Ganesan, Subha Kalyaanamoorthy, Mayank, Parvin Kumar iD, Rajvir Singh, Arvind Negi

ACS Omega · 23.05.2023 · 8 (20) · 17446-17498

DOI: 10.1021/acsomega.3c00692 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Omega, online erschienen am 09.05.2023. Verfasst von Sandhya Chahal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, COBS&H, CCS Haryana Agricultural University, Hisar 125004, India. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, University Grants Commission.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Innate inflammation beyond a threshold is a significant problem involved in cardiovascular diseases, cancer, and many other chronic conditions. Cyclo­oxygenase (COX) enzymes are key inflammatory markers as they catalyze prostaglandins production and are crucial for inflammation processes. While COX-I is constitutively expressed and is generally involved in “housekeeping” roles, the expression of the COX-II isoform is induced by the stimulation of different inflammatory cytokines and also promotes the further generation of pro-inflammatory cytokines and chemokines, which affect the prognosis of various diseases. Hence, COX-II is considered an important therapeutic target for drug development against inflammation-related illnesses. Several selective COX-II inhibitors with safe gastric safety profiles features that do not cause gastrointestinal complications associated with classic anti-inflammatory drugs have been developed. Nevertheless, there is mounting evidence of cardiovascular side effects from COX-II inhibitors that resulted in the withdrawal of market-approved anti-COX-II drugs. This necessitates the development of COX-II inhibitors that not only exhibit inhibit potency but also are free of side effects. Probing the scaffold diversity of known inhibitors is vital to achieving this goal. A systematic review and discussion on the scaffold diversity of COX inhibitors are still limited. To address this gap, herein we present an overview of chemical structures and inhibitory activity of different scaffolds of known COX-II inhibitors. The insights from this article could be helpful in seeding the development of next-generation COX-II inhibitors.

Autor:innen und Institutionen

  • Department of Chemistry, COBS&H, CCS Haryana Agricultural University, Hisar 125004, India.
  • Department of Pharmaceutical Sciences, Hemvati Nandan Bahuguna Garhwal (A Central) University, Chauras Campus, Tehri Garhwal, Uttarakhand 249161, India.
  • Adjunct Faculty at Department of Biotechnology, Graphic Era (Deemed to be) University, 566/6, Bell Road, Clement Town, Dehradun, Uttarakhand 248002, India.
  • ArGan'sLab, School of Pharmacy, University of Waterloo, Waterloo, Ontario N2G 1C5, Canada.
  • Department of Chemistry, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.
  • University College of Pharmacy, Guru Kashi University, Talwandi Sabo, Punjab 151302, India.

ORCID-Profile: Jayant Sindhu, Gaurav Joshi, Parvin Kumar

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India
  • University Grants Commission

Zitieren

APA

Chahal, S., Rani, P., Kiran, Sindhu, J., Joshi, G., Ganesan, A., Kalyaanamoorthy, S., Mayank, Kumar, P., Singh, R., & Negi, A. (2023). Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective. ACS Omega, 8(20), 17446-17498. https://doi.org/10.1021/acsomega.3c00692

Vancouver

Chahal S, Rani P, Kiran, Sindhu J, Joshi G, Ganesan A, et al. Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective. ACS Omega. 2023;8(20):17446-17498. doi:10.1021/acsomega.3c00692

BibTeX
@article{Chahal2023,
  author = {Chahal, Sandhya and Rani, Payal and Kiran and Sindhu, Jayant and Joshi, Gaurav and Ganesan, Aravindhan and Kalyaanamoorthy, Subha and Mayank and Kumar, Parvin and Singh, Rajvir and Negi, Arvind},
  title = {Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective},
  journal = {ACS Omega},
  year = {2023},
  volume = {8},
  number = {20},
  pages = {17446--17498},
  doi = {10.1021/acsomega.3c00692}
}
Kostenlos starten →